Recro Pharma DPO Ratio 2011-2026 | REPH

Annual DPO Ratio Recro Pharma

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
6.63	9.66	12.8	9.42	7.08	38.1	76	40.6	20.2	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
76	6.63	24.5

Quarterly DPO Ratio Recro Pharma

2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
13.9	16.6	9.13	-	15.3	10.2	10.3	-	10.7	9.96	10.6	-	14	14.2	6.98	-	8.18	6.4	9.98	-	48.6	34.1	54.2	-	105	69.5	52.5	-	65.6	39.5	25.2	-	14.1	15.1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
105	6.4	26.6

DPO Ratio of other stocks in the Drug manufacturers industry

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
AcelRx Pharmaceuticals ACRX	38	-	7.5 %	$ 6.35 M	USA
Agile Therapeutics AGRX	352	-	10.11 %	$ 58.2 M	USA
Alimera Sciences ALIM	309	-	-	$ 142 M	USA
Cronos Group CRON	212	$ 2.67	3.49 %	$ 1.37 B	Canada
Adamis Pharmaceuticals Corporation ADMP	345	-	0.86 %	$ 117 M	USA
Aerie Pharmaceuticals AERI	116	-	-	$ 754 M	USA
DURECT Corporation DRRX	519	-	-	$ 50.1 M	USA
Eagle Pharmaceuticals EGRX	75.6	-	-39.89 %	$ 27.7 M	USA
Endo International plc ENDP	39.3	-	-	$ 28.9 M	Irlanda
Catalent CTLT	41.8	-	-	$ 11.5 B	USA
Harrow Health HROW	199	$ 40.53	0.72 %	$ 1.49 B	USA
Athenex ATNX	111	-	-23.39 %	$ 1.76 M	USA
Cumberland Pharmaceuticals CPIX	775	$ 4.19	-0.48 %	$ 58.9 M	USA
Avadel Pharmaceuticals plc AVDL	224	-	-	$ 2.06 B	France
Jupiter Wellness JUPW	318	-	-	$ 33.6 M	USA
Evoke Pharma EVOK	5.36 K	-	-	$ 36.6 M	USA
Bausch Health Companies BHC	78.1	$ 5.72	2.33 %	$ 2.09 B	Canada
Canopy Growth Corporation CGC	52.8	$ 1.11	1.83 %	$ 119 M	Canada
Lannett Company LCI	36.8	-	1.15 %	$ 7.11 M	USA
Evolus EOLS	59.4	$ 5.39	4.05 %	$ 347 M	USA
Emergent BioSolutions EBS	55.8	$ 8.23	3.0 %	$ 421 M	USA
Organogenesis Holdings ORGO	94	$ 2.35	2.17 %	$ 309 M	USA
Pacira BioSciences PCRX	37.3	$ 25.49	1.39 %	$ 1.18 B	USA
ProPhase Labs PRPH	45.4	-	-	$ 5.07 M	USA
Radius Health RDUS	274	-	-	$ 1.42 B	USA
Assertio Holdings ASRT	122	$ 18.43	2.11 %	$ 118 M	USA
PetIQ PETQ	54.2	-	1.64 %	$ 400 M	USA
Sonoma Pharmaceuticals SNOA	32.3	$ 1.1	3.77 %	$ 1.37 M	USA
Tilray TLRY	53	$ 6.24	1.63 %	$ 3.86 B	Canada
OptiNose OPTN	194	-	-	$ 1.08 B	USA
SCYNEXIS SCYX	20.2	$ 0.93	-0.46 %	$ 46.4 M	USA
Veru VERU	264	$ 2.25	0.45 %	$ 303 M	USA
Viatris VTRS	64	$ 14.94	-0.2 %	$ 17.9 B	USA
Aurora Cannabis ACB	-807	$ 3.44	4.56 %	$ 86.3 M	Canada
cbdMD YCBD	84	$ 0.87	0.15 %	$ 3.75 M	USA
Zomedica Corp. ZOM	64.3	-	-0.21 %	$ 98 M	USA
Rockwell Medical RMTI	15.4	$ 0.88	-2.56 %	$ 31.7 M	USA
China Pharma Holdings CPHI	47.6	$ 0.54	-1.78 %	$ 2.32 M	China
TherapeuticsMD TXMD	723	$ 2.04	-3.32 %	$ 23.6 M	USA